Form 8-K - Current report:
SEC Accession No. 0001437749-26-023320
Filing Date
2026-07-10
Accepted
2026-07-10 16:04:50
Documents
12
Period of Report
2026-07-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20260709_8k.htm   iXBRL 8-K 31060
  Complete submission text file 0001437749-26-023320.txt   161867

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA govx-20260707.xsd EX-101.SCH 3578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20260707_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20260707_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20260707_pre.xml EX-101.PRE 11583
15 EXTRACTED XBRL INSTANCE DOCUMENT govx20260709_8k_htm.xml XML 2840
Mailing Address 1955 LAKE PARK DRIVE SUITE 300 SMYRNA GA
Business Address 1955 LAKE PARK DRIVE SUITE 300 SMYRNA GA 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 261168759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)